Global Anti-aging Drugs Market Growth 2025-2031

January 2025 | 118 pages | ID: G730604C073FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Anti-aging Drugs market size is predicted to grow from US$ 10790 million in 2025 to US$ 21690 million in 2031; it is expected to grow at a CAGR of 12.3% from 2025 to 2031.

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.

The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.

LP Information, Inc. (LPI) ' newest research report, the “Anti-aging Drugs Industry Forecast” looks at past sales and reviews total world Anti-aging Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-aging Drugs sales for 2025 through 2031. With Anti-aging Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-aging Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-aging Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-aging Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-aging Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-aging Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-aging Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-aging Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Dermal Fillers
• Botulinum Toxin
• Others

Segmentation by Application:

• Hospital
• Beauty Parlor
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Allergan
• Galderma
• LG Life Science
• Merz Pharma
• Medytox
• Hugel
• IMEIK
• Haohai Bio
• Daewoong Pharmaceutical
• Bloomage
• Suneva Medical
• SciVision Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-aging Drugs market?

What factors are driving Anti-aging Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-aging Drugs market opportunities vary by end market size?

How does Anti-aging Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-aging Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Anti-aging Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Anti-aging Drugs by Country/Region, 2020, 2024 & 2031
2.2 Anti-aging Drugs Segment by Type
  2.2.1 Dermal Fillers
  2.2.2 Botulinum Toxin
  2.2.3 Others
2.3 Anti-aging Drugs Sales by Type
  2.3.1 Global Anti-aging Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Anti-aging Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Anti-aging Drugs Sale Price by Type (2020-2025)
2.4 Anti-aging Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Beauty Parlor
  2.4.3 Others
2.5 Anti-aging Drugs Sales by Application
  2.5.1 Global Anti-aging Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Anti-aging Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Anti-aging Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Anti-aging Drugs Breakdown Data by Company
  3.1.1 Global Anti-aging Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Anti-aging Drugs Sales Market Share by Company (2020-2025)
3.2 Global Anti-aging Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Anti-aging Drugs Revenue by Company (2020-2025)
  3.2.2 Global Anti-aging Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Anti-aging Drugs Sale Price by Company
3.4 Key Manufacturers Anti-aging Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Anti-aging Drugs Product Location Distribution
  3.4.2 Players Anti-aging Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ANTI-AGING DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Anti-aging Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Anti-aging Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Anti-aging Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-aging Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Anti-aging Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Anti-aging Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-aging Drugs Sales Growth
4.4 APAC Anti-aging Drugs Sales Growth
4.5 Europe Anti-aging Drugs Sales Growth
4.6 Middle East & Africa Anti-aging Drugs Sales Growth

5 AMERICAS

5.1 Americas Anti-aging Drugs Sales by Country
  5.1.1 Americas Anti-aging Drugs Sales by Country (2020-2025)
  5.1.2 Americas Anti-aging Drugs Revenue by Country (2020-2025)
5.2 Americas Anti-aging Drugs Sales by Type (2020-2025)
5.3 Americas Anti-aging Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-aging Drugs Sales by Region
  6.1.1 APAC Anti-aging Drugs Sales by Region (2020-2025)
  6.1.2 APAC Anti-aging Drugs Revenue by Region (2020-2025)
6.2 APAC Anti-aging Drugs Sales by Type (2020-2025)
6.3 APAC Anti-aging Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Anti-aging Drugs by Country
  7.1.1 Europe Anti-aging Drugs Sales by Country (2020-2025)
  7.1.2 Europe Anti-aging Drugs Revenue by Country (2020-2025)
7.2 Europe Anti-aging Drugs Sales by Type (2020-2025)
7.3 Europe Anti-aging Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-aging Drugs by Country
  8.1.1 Middle East & Africa Anti-aging Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Anti-aging Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-aging Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-aging Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-aging Drugs
10.3 Manufacturing Process Analysis of Anti-aging Drugs
10.4 Industry Chain Structure of Anti-aging Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Anti-aging Drugs Distributors
11.3 Anti-aging Drugs Customer

12 WORLD FORECAST REVIEW FOR ANTI-AGING DRUGS BY GEOGRAPHIC REGION

12.1 Global Anti-aging Drugs Market Size Forecast by Region
  12.1.1 Global Anti-aging Drugs Forecast by Region (2026-2031)
  12.1.2 Global Anti-aging Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-aging Drugs Forecast by Type (2026-2031)
12.7 Global Anti-aging Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Allergan
  13.1.1 Allergan Company Information
  13.1.2 Allergan Anti-aging Drugs Product Portfolios and Specifications
  13.1.3 Allergan Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Allergan Main Business Overview
  13.1.5 Allergan Latest Developments
13.2 Galderma
  13.2.1 Galderma Company Information
  13.2.2 Galderma Anti-aging Drugs Product Portfolios and Specifications
  13.2.3 Galderma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Galderma Main Business Overview
  13.2.5 Galderma Latest Developments
13.3 LG Life Science
  13.3.1 LG Life Science Company Information
  13.3.2 LG Life Science Anti-aging Drugs Product Portfolios and Specifications
  13.3.3 LG Life Science Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 LG Life Science Main Business Overview
  13.3.5 LG Life Science Latest Developments
13.4 Merz Pharma
  13.4.1 Merz Pharma Company Information
  13.4.2 Merz Pharma Anti-aging Drugs Product Portfolios and Specifications
  13.4.3 Merz Pharma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Merz Pharma Main Business Overview
  13.4.5 Merz Pharma Latest Developments
13.5 Medytox
  13.5.1 Medytox Company Information
  13.5.2 Medytox Anti-aging Drugs Product Portfolios and Specifications
  13.5.3 Medytox Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Medytox Main Business Overview
  13.5.5 Medytox Latest Developments
13.6 Hugel
  13.6.1 Hugel Company Information
  13.6.2 Hugel Anti-aging Drugs Product Portfolios and Specifications
  13.6.3 Hugel Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Hugel Main Business Overview
  13.6.5 Hugel Latest Developments
13.7 IMEIK
  13.7.1 IMEIK Company Information
  13.7.2 IMEIK Anti-aging Drugs Product Portfolios and Specifications
  13.7.3 IMEIK Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 IMEIK Main Business Overview
  13.7.5 IMEIK Latest Developments
13.8 Haohai Bio
  13.8.1 Haohai Bio Company Information
  13.8.2 Haohai Bio Anti-aging Drugs Product Portfolios and Specifications
  13.8.3 Haohai Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Haohai Bio Main Business Overview
  13.8.5 Haohai Bio Latest Developments
13.9 Daewoong Pharmaceutical
  13.9.1 Daewoong Pharmaceutical Company Information
  13.9.2 Daewoong Pharmaceutical Anti-aging Drugs Product Portfolios and Specifications
  13.9.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Daewoong Pharmaceutical Main Business Overview
  13.9.5 Daewoong Pharmaceutical Latest Developments
13.10 Bloomage
  13.10.1 Bloomage Company Information
  13.10.2 Bloomage Anti-aging Drugs Product Portfolios and Specifications
  13.10.3 Bloomage Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Bloomage Main Business Overview
  13.10.5 Bloomage Latest Developments
13.11 Suneva Medical
  13.11.1 Suneva Medical Company Information
  13.11.2 Suneva Medical Anti-aging Drugs Product Portfolios and Specifications
  13.11.3 Suneva Medical Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Suneva Medical Main Business Overview
  13.11.5 Suneva Medical Latest Developments
13.12 SciVision Biotech
  13.12.1 SciVision Biotech Company Information
  13.12.2 SciVision Biotech Anti-aging Drugs Product Portfolios and Specifications
  13.12.3 SciVision Biotech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 SciVision Biotech Main Business Overview
  13.12.5 SciVision Biotech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Anti-aging Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-aging Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DermalFillers
Table 4. Major Players of BotulinumToxin
Table 5. Major Players of Others
Table 6. Global Anti-aging Drugs Sales byType (2020-2025) & (K Units)
Table 7. Global Anti-aging Drugs Sales Market Share byType (2020-2025)
Table 8. Global Anti-aging Drugs Revenue byType (2020-2025) & ($ million)
Table 9. Global Anti-aging Drugs Revenue Market Share byType (2020-2025)
Table 10. Global Anti-aging Drugs Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Anti-aging Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-aging Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Anti-aging Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-aging Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-aging Drugs Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Anti-aging Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-aging Drugs Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Anti-aging Drugs Producing Area Distribution and Sales Area
Table 22. Players Anti-aging Drugs Products Offered
Table 23. Anti-aging Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-aging Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-aging Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-aging Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-aging Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-aging Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-aging Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-aging Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-aging Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-aging Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-aging Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-aging Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-aging Drugs Sales byType (2020-2025) & (K Units)
Table 38. Americas Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-aging Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-aging Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-aging Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-aging Drugs Sales byType (2020-2025) & (K Units)
Table 43. APAC Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-aging Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-aging Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-aging Drugs Sales byType (2020-2025) & (K Units)
Table 47. Europe Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-aging Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-aging Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-aging Drugs Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-aging Drugs
Table 53. Key Market Challenges & Risks of Anti-aging Drugs
Table 54. Key IndustryTrends of Anti-aging Drugs
Table 55. Anti-aging Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-aging Drugs Distributors List
Table 58. Anti-aging Drugs Customer List
Table 59. Global Anti-aging Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-aging Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-aging Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-aging Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-aging Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-aging Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-aging Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-aging Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-aging Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-aging Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-aging Drugs SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Anti-aging Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Anti-aging Drugs SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-aging Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Allergan Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Allergan Anti-aging Drugs Product Portfolios and Specifications
Table 75. Allergan Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Allergan Main Business
Table 77. Allergan Latest Developments
Table 78. Galderma Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Galderma Anti-aging Drugs Product Portfolios and Specifications
Table 80. Galderma Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Galderma Main Business
Table 82. Galderma Latest Developments
Table 83. LG Life Science Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. LG Life Science Anti-aging Drugs Product Portfolios and Specifications
Table 85. LG Life Science Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. LG Life Science Main Business
Table 87. LG Life Science Latest Developments
Table 88. Merz Pharma Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Merz Pharma Anti-aging Drugs Product Portfolios and Specifications
Table 90. Merz Pharma Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Merz Pharma Main Business
Table 92. Merz Pharma Latest Developments
Table 93. Medytox Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Medytox Anti-aging Drugs Product Portfolios and Specifications
Table 95. Medytox Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Medytox Main Business
Table 97. Medytox Latest Developments
Table 98. Hugel Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Hugel Anti-aging Drugs Product Portfolios and Specifications
Table 100. Hugel Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Hugel Main Business
Table 102. Hugel Latest Developments
Table 103. IMEIK Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. IMEIK Anti-aging Drugs Product Portfolios and Specifications
Table 105. IMEIK Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. IMEIK Main Business
Table 107. IMEIK Latest Developments
Table 108. Haohai Bio Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Haohai Bio Anti-aging Drugs Product Portfolios and Specifications
Table 110. Haohai Bio Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Haohai Bio Main Business
Table 112. Haohai Bio Latest Developments
Table 113. Daewoong Pharmaceutical Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Daewoong Pharmaceutical Anti-aging Drugs Product Portfolios and Specifications
Table 115. Daewoong Pharmaceutical Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Daewoong Pharmaceutical Main Business
Table 117. Daewoong Pharmaceutical Latest Developments
Table 118. Bloomage Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Bloomage Anti-aging Drugs Product Portfolios and Specifications
Table 120. Bloomage Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Bloomage Main Business
Table 122. Bloomage Latest Developments
Table 123. Suneva Medical Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Suneva Medical Anti-aging Drugs Product Portfolios and Specifications
Table 125. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Suneva Medical Main Business
Table 127. Suneva Medical Latest Developments
Table 128. SciVision Biotech Basic Information, Anti-aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. SciVision Biotech Anti-aging Drugs Product Portfolios and Specifications
Table 130. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. SciVision Biotech Main Business
Table 132. SciVision Biotech Latest Developments



LIST OFFIGURES

Figure 1. Picture of Anti-aging Drugs
Figure 2. Anti-aging Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-aging Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-aging Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-aging Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-aging Drugs Sales Market Share by Country/Region (2024)
Figure 10. Anti-aging Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of DermalFillers
Figure 12. Product Picture of BotulinumToxin
Figure 13. Product Picture of Others
Figure 14. Global Anti-aging Drugs Sales Market Share byType in 2025
Figure 15. Global Anti-aging Drugs Revenue Market Share byType (2020-2025)
Figure 16. Anti-aging Drugs Consumed in Hospital
Figure 17. Global Anti-aging Drugs Market: Hospital (2020-2025) & (K Units)
Figure 18. Anti-aging Drugs Consumed in Beauty Parlor
Figure 19. Global Anti-aging Drugs Market: Beauty Parlor (2020-2025) & (K Units)
Figure 20. Anti-aging Drugs Consumed in Others
Figure 21. Global Anti-aging Drugs Market: Others (2020-2025) & (K Units)
Figure 22. Global Anti-aging Drugs Sale Market Share by Application (2024)
Figure 23. Global Anti-aging Drugs Revenue Market Share by Application in 2025
Figure 24. Anti-aging Drugs Sales by Company in 2025 (K Units)
Figure 25. Global Anti-aging Drugs Sales Market Share by Company in 2025
Figure 26. Anti-aging Drugs Revenue by Company in 2025 ($ millions)
Figure 27. Global Anti-aging Drugs Revenue Market Share by Company in 2025
Figure 28. Global Anti-aging Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Anti-aging Drugs Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Anti-aging Drugs Sales 2020-2025 (K Units)
Figure 31. Americas Anti-aging Drugs Revenue 2020-2025 ($ millions)
Figure 32. APAC Anti-aging Drugs Sales 2020-2025 (K Units)
Figure 33. APAC Anti-aging Drugs Revenue 2020-2025 ($ millions)
Figure 34. Europe Anti-aging Drugs Sales 2020-2025 (K Units)
Figure 35. Europe Anti-aging Drugs Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Anti-aging Drugs Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Anti-aging Drugs Revenue 2020-2025 ($ millions)
Figure 38. Americas Anti-aging Drugs Sales Market Share by Country in 2025
Figure 39. Americas Anti-aging Drugs Revenue Market Share by Country (2020-2025)
Figure 40. Americas Anti-aging Drugs Sales Market Share byType (2020-2025)
Figure 41. Americas Anti-aging Drugs Sales Market Share by Application (2020-2025)
Figure 42. United States Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Anti-aging Drugs Sales Market Share by Region in 2025
Figure 47. APAC Anti-aging Drugs Revenue Market Share by Region (2020-2025)
Figure 48. APAC Anti-aging Drugs Sales Market Share byType (2020-2025)
Figure 49. APAC Anti-aging Drugs Sales Market Share by Application (2020-2025)
Figure 50. China Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. India Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Anti-aging Drugs Sales Market Share by Country in 2025
Figure 58. Europe Anti-aging Drugs Revenue Market Share by Country (2020-2025)
Figure 59. Europe Anti-aging Drugs Sales Market Share byType (2020-2025)
Figure 60. Europe Anti-aging Drugs Sales Market Share by Application (2020-2025)
Figure 61. Germany Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62.France Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Anti-aging Drugs Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Anti-aging Drugs Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Anti-aging Drugs Sales Market Share by Application (2020-2025)
Figure 69. Egypt Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Anti-aging Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-aging Drugs in 2025
Figure 75. Manufacturing Process Analysis of Anti-aging Drugs
Figure 76. Industry Chain Structure of Anti-aging Drugs
Figure 77. Channels of Distribution
Figure 78. Global Anti-aging Drugs Sales MarketForecast by Region (2026-2031)
Figure 79. Global Anti-aging Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Anti-aging Drugs Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Anti-aging Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Anti-aging Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Anti-aging Drugs Revenue Market ShareForecast by Application (2026-2031)